Connie Clabots

7.5k citations

80 papers · 5.1k indexed · h-index 39

Impact in

Molecular Medicine top 0.1%
- Antibiotic Resistance in Bacteria
Endocrinology top 0.1%
- Escherichia coli research studies

Papers in

Endocrinology 51
- Escherichia coli research studies 47
Molecular Medicine 31
- Antibiotic Resistance in Bacteria 31

Co-authors: James R. Johnson Dale N. Gerding Lance R. Peterson Stuart Johnson Brian Johnston Mary M. Olson Michael A. Kuskowski Stephen B. Porter
Journals: Journal of Clinical Microbiology (13 papers)Antimicrobial Agents and Chemotherapy (9 papers)The Journal of Infectious Diseases (8 papers)Infection and Immunity (6 papers)Open Forum Infectious Diseases (5 papers)
Partner nations: United States Australia Germany

In The Last Decade

Connie Clabots

79 papers receiving 4.9k citations

Peers

Countries citing papers authored by Connie Clabots

Since Specialization

Citations

This map shows the geographic impact of Connie Clabots's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Connie Clabots with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Connie Clabots more than expected).

Fields of papers citing papers by Connie Clabots

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Connie Clabots. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Connie Clabots. The network helps show where Connie Clabots may publish in the future.

Co-authors

The 25 scholars most cited alongside Connie Clabots, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Connie Clabots Line = papers co-authored together Connie Clabots links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Longitudinal molecular analysis of clinical and fecal Escherichia coli isolates at a Veterans Affairs Medical Center in Minnesota, USA, 2012–2019 Frontiers in Microbiology ·Connie Clabots, Paul Thuras, James R. Johnson	2024	0
2	Gut microbiome predictors of Escherichia coli sequence type 131 colonization and loss EBioMedicine ·Daniel E. Park, Maliha Aziz, Benjamin J. Koch, 敏雄中山, Connie Clabots, James R. Johnson, Lance B. Price, Cindy M. Liu	2023	2
3	Bacteriophage Cocktail and Microcin-Producing Probiotic Escherichia coli Protect Mice Against Gut Colonization With Multidrug-Resistant Escherichia coli Sequence Type 131 Frontiers in Microbiology ·Stephen B. Porter, Brian Johnston, Dagmara Kisiela, Connie Clabots, Evgeni V. Sokurenko, James R. Johnson	2022	21
4	Activity of cefiderocol, ceftazidime-avibactam, and eravacycline against extended-spectrum cephalosporin-resistant Escherichia coli clinical isolates (2012–20017) in relation to phylogenetic background, sequence type 131 subclones, blaCTX-M genotype, and coresistance Diagnostic Microbiology and Infectious Disease ·Brian Johnston, Paul Thuras, Stephen B. Porter, Connie Clabots, S.P. Jensen	2021	6
5	Contribution of yersiniabactin to the virulence of an Escherichia coli sequence type 69 (“clonal group A”) cystitis isolate in murine models of urinary tract infection and sepsis Microbial Pathogenesis ·James R. Johnson, Giuseppe Magistro, Connie Clabots, Stephen B. Porter, Amee R. Manges, Paul Thuras, Sören Schubert	2018	14
6	Virulence genes and subclone status as markers of experimental virulence in a murine sepsis model among Escherichia coli sequence type 131 clinical isolates from Spain PLoS ONE ·Irene Merino, Stephen B. Porter, Brian Johnston, Connie Clabots, Evelyn Shaw, Juan Pablo Horcajada, Rafael Cantón, Patricia Ruíz-Garbajosa, James R. Johnson, (unknown)	2017	8
7	Clinical and Microbiological Determinants of Infection After Transrectal Prostate Biopsy Clinical Infectious Diseases ·Michael A. Liss, James R. Johnson, Stephen B. Porter, Brian Johnston, Connie Clabots, Ke Yang, Unwanaobong Nseyo, Bjorn Lund, Kyoko Sakamoto, Joshua Fierer	2014	47
8	OxyR contributes to the virulence of a Clonal Group A Escherichia coli strain (O17:K+:H18) in animal models of urinary tract infection, subcutaneous infection, and systemic sepsis Microbial Pathogenesis ·James R. Johnson, Thomas A. Russo, Sarah M. Drawz, Connie Clabots, Ruth Olson, Michael A. Kuskowski, Henry Rosen	2013	14
9	Fluoroquinolone-resistant extraintestinal Escherichia coli clinical isolates representing the O15:K52:H1 clonal group from humans and dogs in Australia Comparative Immunology Microbiology and Infectious Diseases ·Joanne L. Platell, Rowland N. Cobbold, James R. Johnson, Connie Clabots, Darren J. Trott	2012	7
10	Molecular Epidemiology ofClostridium difficileover the Course of 10 Years in a Tertiary Care Hospital Clinical Infectious Diseases ·Jaime Belmares, Stuart Johnson, Jorge P. Parada, Mary M. Olson, Connie Clabots, Ganna Prihodko, Lance R. Peterson, Dale N. Gerding	2009	40
11	Virulence genotypes and phylogenetic background of fluoroquinolone-resistant and susceptible Escherichia coli urine isolates from dogs with urinary tract infection Veterinary Microbiology ·James R. Johnson, Michael A. Kuskowski, Krista Owens, Connie Clabots, Randall S. Singer	2008	35
12	Antimicrobial Drug–Resistant Escherichia coli from Humans and Poultry Products, Minnesota and Wisconsin, 2002–2004 Emerging infectious diseases ·James R. Johnson, Mark R. Sannes, Zhaoyang Xiang, Brian Johnston, Connie Clabots, Michael A. Kuskowski, Jeff B. Bender, Kirk Smith, Patricia Winokur, Edward A. Belongia	2007	192
13	Phylogenetic relationships among clonal groups of extraintestinal pathogenic Escherichia coli as assessed by multi-locus sequence analysis Microbes and Infection ·James R. Johnson, Krista Owens, Connie Clabots, Scott J. Weissman, Steven B. Cannon	2006	68
14	Effect of Inactivation of the Global Oxidative Stress Regulator oxyR on the Colonization Ability of Escherichia coli O1:K1:H7 in a Mouse Model of Ascending Urinary Tract Infection Infection and Immunity ·James R. Johnson, Connie Clabots, Henry Rosen	2005	49
15	Effectiveness of Liquid Soap vs. Chlorhexidine Gluconate for the Removal of Clostridium difficile from Bare Hands and Gloved Hands Infection Control and Hospital Epidemiology ·K M Bettin, Connie Clabots, Matthew J. Valdez, Keith E. Willard, Dale N. Gerding	1994	68
16	Wide Diversity Of Clostridium Difficile Types At A Tertiary Referral Hospital The Journal of Infectious Diseases ·Matthew H. Samore, K M Bettin, Paola C. DeGirolami, Connie Clabots, Dale N. Gerding, Adolf W. Karchmer	1994	67
17	Medical technologists using molecular epidemiology as part of the infection control team Diagnostic Microbiology and Infectious Disease ·Lance R. Peterson, Robert A. Petzel, Connie Clabots, Claudine E. Fasching, Dale N. Gerding	1993	18
18	Nosocomial Clostridium difficile colonisation and disease The Lancet ·(unknown), Stuart Johnson, Connie Clabots, Mona Ghoniem, Mary M. Olson, Lance R. Peterson, Dale N. Gerding, (unknown), Mona Ghoniem, Dale N. Gerding	1990	265
19	Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission The American Journal of Medicine ·Stuart Johnson, Dale N. Gerding, Mary M. Olson, Mary Weiler, Rita Hughes, Connie Clabots, Lance R. Peterson	1990	241
20	Clostridium difficile plasmid isolation as an epidemiologic tool European Journal of Clinical Microbiology & Infectious Diseases ·Connie Clabots, Montes Castillo, Dale N. Gerding, Maury E. Mulligan, R Y Kwok, Dennis R. Schaberg, Robert Fekety, Lance R. Peterson	1988	15

About Connie Clabots

Connie Clabots is a scholar working on Endocrinology, Molecular Medicine, Infectious Diseases, Critical Care and Intensive Care Medicine and Clinical Biochemistry, having authored 80 papers that have together received 5.1k indexed citations. Recurring topics across this work include Escherichia coli research studies (47 papers), Antibiotic Resistance in Bacteria (31 papers), Clostridium difficile and Clostridium perfringens research (26 papers), Urinary Tract Infections Management (22 papers), Salmonella and Campylobacter epidemiology (15 papers), Viral gastroenteritis research and epidemiology (14 papers), Antimicrobial Resistance in Staphylococcus (8 papers) and Gut microbiota and health (8 papers). The work is most often cited by research in Molecular Medicine (1.8k citations), Endocrinology (1.8k citations), Infectious Diseases (2.2k citations), Critical Care and Intensive Care Medicine (498 citations) and Applied Microbiology and Biotechnology (132 citations). Connie Clabots has collaborated with scholars based in United States, Australia and Germany. Frequent co-authors include James R. Johnson, Dale N. Gerding, Lance R. Peterson, Stuart Johnson, Brian Johnston, Mary M. Olson, Michael A. Kuskowski, Dale N. Gerding, Stephen B. Porter and K M Bettin. Their work appears in journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy, The Journal of Infectious Diseases, Infection and Immunity and Open Forum Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact